Your browser doesn't support javascript.
loading
Cigarette Smoking Status and Substance Use in Pregnancy.
Oga, Emmanuel A; Mark, Katrina; Coleman-Cowger, Victoria H.
Afiliación
  • Oga EA; Battelle Public Health Center for Tobacco Research, 6115 Falls Rd, Baltimore, MD, 21209, USA. imanueloga@gmail.com.
  • Mark K; Department of OB/GYN and Reproductive Sciences, University of Maryland School of Medicine, 11 S Paca St, Baltimore, MD, 21201, USA.
  • Coleman-Cowger VH; Battelle Public Health Center for Tobacco Research, 6115 Falls Rd, Baltimore, MD, 21209, USA.
Matern Child Health J ; 22(10): 1477-1483, 2018 Oct.
Article en En | MEDLINE | ID: mdl-29882032
ABSTRACT
Objectives Substance use during pregnancy is a significant public health issue. Prenatal substance use increased in the past decade while prenatal cigarette smoking has remained stable. Co-use of tobacco and other drugs is a concern because of potential additive risks. This study aims to describe the prevalence rates of substance use among pregnant women and examine the association between smoking status (nonsmoker, recent quitter and current smoker) and other drug use. Methods In this cross-sectional study, pregnant women (n = 500) were recruited from two obstetric practices to complete three substance use screeners and have their urine tested for 12 different drug classes, including cannabis, opioids and cocaine. Participants were divided into three groups based on survey responses nonsmokers, recent quitters (smoked in the month prior to pregnancy but not past month) and current smokers (past-month). Results Approximately 29% of participants reported smoking in the month before pregnancy. During pregnancy, 17, 12 and 71% were current smokers, recent quitters and nonsmokers respectively. Overall prevalence of illicit or prescription drug use in pregnancy was 27%. Cannabis was the most common drug used in pregnancy with prevalence of 22%, followed by opioids (4%), cocaine (1%), tricyclic antidepressants (TCAs) (1%), amphetamines (1%), and benzodiazepines (1%). On multivariable logistic regression, smoking in pregnancy was associated with a positive urine drug screen; with adjusted odds ratio (aOR) 4.7 (95% CI 2.6-8.3) for current smokers and 1.6 (95% CI 0.8-3.3) for recent quitters. Factors negatively associated with positive drug screen were second and third trimester pregnancies, 0.5 (0.3-0.9) and 0.3 (0.2-0.6) respectively; and employment, 0.5 (0.3-0.8). Conclusions for Practice Co-use of tobacco and illicit drugs, particularly cannabis, is relatively high during pregnancy. Additional research is needed to understand the health implications of co-use versus use of tobacco only. Given the strong association between smoking and other drug use, clinicians should routinely assess for illicit drug use in women who smoke during pregnancy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones del Embarazo / Cese del Hábito de Fumar / Trastornos Relacionados con Sustancias / Cese del Uso de Tabaco / Mujeres Embarazadas / Fumar Cigarrillos Tipo de estudio: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Matern Child Health J Asunto de la revista: PERINATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones del Embarazo / Cese del Hábito de Fumar / Trastornos Relacionados con Sustancias / Cese del Uso de Tabaco / Mujeres Embarazadas / Fumar Cigarrillos Tipo de estudio: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Matern Child Health J Asunto de la revista: PERINATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos